Key result
Bipolar ablation between coronary veins and LVOT/RVOT is linked to an ~82% reduction in PVC burden.
Why the study?
Catheter ablation of PVCs and VT from the left ventricular summit may require advanced techniques, and the outcomes of bipolar ablation between the coronary venous system and adjacent endocardial LVOT or RVOT needed investigation.
Does bipolar radiofrequency ablation between the coronary venous system and adjacent endocardium improve arrhythmia elimination in patients with refractory left ventricular summit PVC/VT?
Observational (n=20)
Yes
Does bipolar radiofrequency ablation between the coronary venous system and adjacent endocardium improve arrhythmia elimination in patients with refractory left ventricular summit PVC/VT?
Absolute Event Rate: 4% vs 22%
p-value: p=<0.001
Bipolar radiofrequency ablation between the coronary venous system and adjacent endocardium is a safe and effective bailout strategy for left ventricular summit arrhythmias refractory to standard unipolar ablation.
May support bipolar ablation for refractory LV summit PVC/VT; leaves open need for randomized confirmation of arrhythmia-free survival.
BackgroundCatheter ablation of premature ventricular complexes (PVCs) and ventricular tachycardia (VT) from the left ventricular summit (LVS) may require advanced ablation techniques. Bipolar ablation from the coronary veins and adjacent endocardial structures can be effective for refractory LVS arrhythmias.ObjectiveThe aim of this study was to investigate the outcomes of bipolar ablation performed between the coronary venous system and adjacent endocardial left ventricular outflow tract (LVOT) or right ventricular outflow tract (RVOT).MethodsThis multicenter study included consecutive patients with LVS PVC/VT who underwent bipolar ablation between the anterior interventricular vein (AIV) or great cardiac vein (GCV) and the endocardial LVOT/RVOT after failed unipolar ablation. Ablation was started with powers of 10–20 W and uptitrated to achieve an impedance drop of at least 10%. Angiography was performed in all cases to confirm a safe distance (>5 mm) of the catheter from the major coronary arteries.ResultsBetween 2013 and 2023, bipolar radiofrequency ablation between the AIV/GCV and the adjacent LVOT/RVOT was attempted in 20 patients (4 female; age 57 ± 16 years). Unipolar ablation from sites of early activation (AIV/GCV, LVOT, aortic cusps, RVOT) failed to effectively suppress the PVC/VT in all subjects. Bipolar ablation was delivered with a maximum power of 30 ± 8 W and total duration of 238 ± 217 s and led to acute PVC/VT elimination in all patients. No procedural-related complications occurred. Over a follow-up period of 30 ± 24 months, the freedom from arrhythmia recurrence was 85% (1 recurrence in the VT group and 2 in the PVC group). PVC burden was reduced from 22% ± 10% to 4% ± 8% (P <.001).ConclusionIn cases of LVS PVC/VT refractory to unipolar ablation, bipolar ablation between the coronary venous system and adjacent endocardial LVOT/RVOT is safe and effective if careful titration of power and intraprocedural angiography are performed to ensure a safe distance from the coronary arteries. Catheter ablation of premature ventricular complexes (PVCs) and ventricular tachycardia (VT) from the left ventricular summit (LVS) may require advanced ablation techniques. Bipolar ablation from the coronary veins and adjacent endocardial structures can be effective for refractory LVS arrhythmias. The aim of this study was to investigate the outcomes of bipolar ablation performed between the coronary venous system and adjacent endocardial left ventricular outflow tract (LVOT) or right ventricular outflow tract (RVOT). This multicenter study included consecutive patients with LVS PVC/VT who underwent bipolar ablation between the anterior interventricular vein (AIV) or great cardiac vein (GCV) and the endocardial LVOT/RVOT after failed unipolar ablation. Ablation was started with powers of 10–20 W and uptitrated to achieve an impedance drop of at least 10%. Angiography was performed in all cases to confirm a safe distance (>5 mm) of the catheter from the major coronary arteries. Between 2013 and 2023, bipolar radiofrequency ablation between the AIV/GCV and the adjacent LVOT/RVOT was attempted in 20 patients (4 female; age 57 ± 16 years). Unipolar ablation from sites of early activation (AIV/GCV, LVOT, aortic cusps, RVOT) failed to effectively suppress the PVC/VT in all subjects. Bipolar ablation was delivered with a maximum power of 30 ± 8 W and total duration of 238 ± 217 s and led to acute PVC/VT elimination in all patients. No procedural-related complications occurred. Over a follow-up period of 30 ± 24 months, the freedom from arrhythmia recurrence was 85% (1 recurrence in the VT group and 2 in the PVC group). PVC burden was reduced from 22% ± 10% to 4% ± 8% (P <.001). In cases of LVS PVC/VT refractory to unipolar ablation, bipolar ablation between the coronary venous system and adjacent endocardial LVOT/RVOT is safe and effective if careful titration of power and intraprocedural angiography are performed to ensure a safe distance from the coronary arteries.
No takes yet. Share an insight, caveat, or question.
Enríquez et al. (2023) conducted an observational in Refractory left ventricular summit premature ventricular complexes and ventricular tachycardia (n=20). Bipolar radiofrequency ablation between the coronary venous system and adjacent endocardial LVOT/RVOT vs. Baseline (prior to bipolar ablation) was evaluated on Premature ventricular complex (PVC) burden (p=<0.001). Bipolar ablation between the coronary venous system and adjacent endocardial LVOT/RVOT reduced PVC burden from 22% to 4% (P<0.001) and achieved 85% freedom from recurrence at 30 months.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: